The Impact of Steroid Use on Scabies Treatment: An Evaluation of Clinical Severity, Parasite Burden, and the Validity of a Novel Scoring System
International Journal of Dermatology · 2026-09 · 65 (9) · 1856-1863
DOI: 10.1111/ijd.70326 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift International Journal of Dermatology, online erschienen am 01.03.2026. Verfasst von Semih Güder und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Bezmialem Vakıf University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Scabies, Severity of Illness Index, Adrenal Cortex Hormones, Glucocorticoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Corticosteroids are frequently used to relieve pruritus or eczematization in scabies, but empirical or prolonged use before diagnosis may modify the disease course.
Objectives
This study aimed to examine the impact of corticosteroid exposure (misdiagnosis‐related or adjunctive) on clinical severity, mite burden, and healing time, and to assess the initial measurement properties of a novel composite scoring system for standardized severity assessment.
Methods
In this cross‐sectional analytical study, 180 adults (18–50 years) with dermoscopically confirmed scabies were classified into three groups: misdiagnosed (steroid‐only), standard therapy + steroid, and standard therapy. Severity was assessed using a 0–9 composite score integrating pruritus (NRS), mite index, and body surface area involvement (BSA). Internal consistency (Cronbach's α ) and inter‐rater reliability (ICC) were evaluated.
Results
Both steroid‐exposed groups showed significantly higher severity scores (all p < 0.001), longer disease duration (median 8 weeks vs. 3 weeks), and delayed healing compared with standard therapy. Steroid duration correlated with mite index, BSA, and total score (all p ≤ 0.005). The scale showed borderline‐to‐acceptable internal consistency; ICC was good for NRS (0.79) and fair‐to‐moderate for the total score (0.45).
Conclusion
Prior or concurrent corticosteroid exposure increases disease severity and delays recovery in scabies, likely by suppressing local immune responses. The proposed Scabies Severity Scale is a practical, preliminary tool for standardized severity assessment, pending external validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Bezmialem Vakıf University, Istanbul, Turkey.
- Department of Dermatology, Maltepe University, Istanbul, Turkey.
ORCID-Profile: Semih Güder, Özlem Su Küçük, Didem Dizman, Sera Nur Yücesoy Temiz, Güllü Gencebay, Melisa Özay, Hüsna Güder
Zitieren
APA
Güder, S., Küçük, Ö. S., Dizman, D., Temiz, S. N. Y., Gencebay, G., Özay, M., & Güder, H. (2026). The Impact of Steroid Use on Scabies Treatment: An Evaluation of Clinical Severity, Parasite Burden, and the Validity of a Novel Scoring System. International Journal of Dermatology, 65(9), 1856-1863. https://doi.org/10.1111/ijd.70326
Vancouver
Güder S, Küçük ÖS, Dizman D, Temiz SNY, Gencebay G, Özay M, et al. The Impact of Steroid Use on Scabies Treatment: An Evaluation of Clinical Severity, Parasite Burden, and the Validity of a Novel Scoring System. International Journal of Dermatology. 2026;65(9):1856-1863. doi:10.1111/ijd.70326
BibTeX
@article{Gder2026,
author = {Güder, Semih and Küçük, Özlem Su and Dizman, Didem and Temiz, Sera Nur Yücesoy and Gencebay, Güllü and Özay, Melisa and Güder, Hüsna},
title = {The Impact of Steroid Use on Scabies Treatment: An Evaluation of Clinical Severity, Parasite Burden, and the Validity of a Novel Scoring System},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {9},
pages = {1856--1863},
doi = {10.1111/ijd.70326}
}
EUVIMED